The document summarizes properties and clinical applications of mineral trioxide aggregate (MTA). MTA was introduced in 1993 as a root-end filling material and to repair lateral perforations. It has received FDA approval. MTA is biocompatible and promotes regeneration when placed in contact with tissues. It exists in gray and white forms. MTA has excellent sealing ability and marginal adaptation compared to other materials. It induces hard tissue formation and has dentinogenic effects when used for pulp capping or pulpotomy. MTA demonstrates regenerative capabilities and stimulates tissue healing.